Healthcare >> Analyst Interviews >> October 12, 2001
GEOFFREY HARRIS, CFA is Head of Global Healthcare Research and Managing
Director at UBS Warburg, specializing in large capitalization
biotechnology companies. He was previously associated with Salomon Smith
Barney and covered Managed Care and Hospital Management companies.
Before that, Mr. Harris was a Senior Analyst at Tucker Anthony, Inc.,
and Loomis Sayles & Co. He received a BA in Economics from Oberlin
College and an MA in Management Science from The Sloan School of
Management at MIT. Profile
ANNABEL SAMIMY is an Associate Director in the healthcare group of UBS
Warburg Equity Research. An analyst since 1999, Ms. Samimy specializes
in the large capitalization biotechnology sector, with special areas of
interest in monoclonal antibody technologies, cancer and autoimmune
disease. Previously at UBS Warburg, Ms. Samimy worked as an Associate in
the structured finance group. Ms. Samimy received her MA in
International Affairs with a focus on International Finance and Business
from Columbia University and a BA in International Relations from Tufts
University. Profile
coverage areas for your analysts?
Mr. Harris: We have a worldwide team that covers all of the major
sectors in health care.
